EWSR1-NFATC2

Mohamed A Gouda1, Maria A Zarzour2, Ara A Vaporciyan3

  • 1Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Oncoscience
|September 22, 2023
PubMed
概括

帕佐帕尼布在患有罕见的EWSR1-NFATC2融合阳性骨肉瘤的患者中显示出异常的瘤控制超过五年. 这一案例突出了帕索帕尼比的存在.